Read More

What’s Happening With Eli Lilly Shares On Monday?

Eli Lilly reports detailed results from the SYNERGY-NASH phase 2 study. The trial, involving 190 patients with and without type 2 diabetes, showed tirzepatide met the primary endpoint, achieving MASH resolution without fibrosis worsening. Participants taking 5 mg, 10 mg, and 15 mg doses saw significant improvements compared to placebo, presented at the EASL Congress 2024.

LLY

Read More

Critical Metals Secures ~$211M Deal For Tanbreez Rare Earth Mine To Counter China

Critical Metals Corp. (NASDAQ: CRML) has signed an agreement to acquire a controlling interest in the Tanbreez Greenland Rare Earth Mine from Rimbal Pty Ltd. The Tanbreez Project, permitted by the Greenland Government, will enhance the supply of valuable heavy rare earth elements (HREEs) for electrification and next-gen technologies in Europe and North America, offering sustainable and long-term solutions.

CRML